Register for updates

 
 

Medicine & Health
RSS Feed
Cardiac Stem Cells from Heart Disease Patients May Be Harmful
Thursday, June 15, 2017 9:00:00 AM

TAU researchers discover molecular pathway involved in toxic interaction between host cells and immune system

Patients with severe and end-stage heart failure have few treatment options available to them apart from transplants and "miraculous" stem cell therapy. But a new Tel Aviv University study finds that stem cell therapy may, in fact, harm heart disease patients.

The research, led by Prof. Jonathan Leor of TAU's Sackler Faculty of Medicine and Sheba Medical Center and conducted by TAU's Dr. Nili Naftali-Shani, explores the current practice of using cells from the host patient to repair tissue — and contends that this can prove deleterious or toxic for patients. The study was recently published in the journal Circulation.

"We found that, contrary to popular belief, tissue stem cells derived from sick hearts do not contribute to heart healing after injury," said Prof. Leor. "Furthermore, we found that these cells are affected by the inflammatory environment and develop inflammatory properties. The affected stem cells may even exacerbate damage to the already diseased heart muscle."

Tissue or adult stem cells — "blank" cells that can act as a repair kit for the body by replacing damaged tissue — encourage the regeneration of blood vessel cells and new heart muscle tissue. Faced with a worse survival rate than many cancers, many heart failure patients have turned to stem cell therapy as a last resort.

"But our findings suggest that stem cells, like any drug, can have adverse effects," said Prof. Leor. "We concluded that stem cells used in cardiac therapy should be drawn from healthy donors or be better genetically engineered for the patient."

Hope for improved cardiac stem cell therapy

In addition, the researchers also discovered the molecular pathway involved in the negative interaction between stem cells and the immune system as they isolated stem cells in mouse models of heart disease. After exploring the molecular pathway in mice, the researchers focused on cardiac stem cells in patients with heart disease.

The results could help improve the use of autologous stem cells — those drawn from the patients themselves — in cardiac therapy, Prof. Leor said.

"We showed that the deletion of the gene responsible for this pathway can restore the original therapeutic function of the cells," said Prof. Leor. "Our findings determine the potential negative effects of inflammation on stem cell function as they're currently used. The use of autologous stem cells from patients with heart disease should be modified. Only stem cells from healthy donors or genetically engineered cells should be used in treating cardiac conditions."

The researchers are currently testing a gene editing technique (CRISPER) to inhibit the gene responsible for the negative inflammatory properties of the cardiac stem cells of heart disease patients. "We hope our engineered stem cells will be resistant to the negative effects of the immune system," said Prof. Leor.




Latest News

Marine Vessels are Unsuspecting Hosts of Invasive Species

Half of the ships passing along the Mediterranean coast of Israel carry damaging ascidians, TAU researchers say.

Inauguration of Steinhardt Museum of Natural History Celebrated at TAU on June 26

Historic event held in presence of philanthropist Michael Steinhardt and family, TAU governors, board members and faculty.

Baxter, Ramot at TAU and Tel Aviv Sourasky Medical Center Partner to Bring New Surgical Innovations Worldwide

Agreements will explore potential applications of promising early-stage research in areas of unmet need.

3,000-Year-Old Textiles Are Earliest Evidence of Chemical Dyeing in The Levant

Discovery provides insight into society and copper production in the Timna region at the time of David and Solomon, TAU researchers say.

Zuckerman Scholar Launches State-of-the-Art Laser Laboratory at TAU

Dr. Ishay Pomerantz hopes to lower the cost and size of particle accelerators for more practical social applications.

The Brain Mechanism Behind Multitasking

The brief reactivation of a learned memory can block interference from competing tasks, TAU researchers say.

DNA Delivery Technology Joins Battle Against Drug-Resistant Bacteria

New tool is major milestone against lethal condition, TAU researchers say.

Cardiac Stem Cells from Heart Disease Patients May Be Harmful

TAU researchers discover molecular pathway involved in toxic interaction between host cells and immune system.

Multispectral Imaging Reveals Ancient Hebrew Inscription Undetected for Over 50 Years

Military correspondence from the First Temple period discovered on reverse side of well-studied artifact at The Israel Museum, TAU researchers say.

Earliest Human Impact on the Environment Took Place 11,500 Years Ago

The earliest geological indication of humans' impact on the environment discovered in the Dead Sea, TAU researchers say.

IDEAS Immersion Program to Host Nine Female Entrepreneurs from TAU

Acceleration program partners with Cross Campus and Google to help budding women entrepreneurs incubate startups.

Prof. Jacob A. Frenkel Elected to Second Term as Chairman of TAU's Board of Governors

Internationally-acclaimed economist will continue to "greatly contribute to the further development of Tel Aviv University," said TAU President Prof. Yossi Klafter.

Solving the Riddle of the Snow Globe

TAU research explains the process of sedimentation in natural and industrial contexts.

contentSecondary
c

© 2017 American Friends of Tel Aviv University
39 Broadway, Suite 1510 | New York, NY 10006 | 212.742.9070 | info@aftau.org
Privacy policy | Tel Aviv University